KRP-104Phase 2 Dose Finding Study -Investigation on Type2 Diabetes Mellitus
Phase 2
- Conditions
- Type2 Diabetes Mellitus
- Registration Number
- JPRN-jRCT2080220708
- Lead Sponsor
- Kyorin Pharmaceutical Co.,LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Inclusion Criteria;
-Diagnosis of type 2 diabetes
-Outpatients
etc.
Exclusion Criteria
Exclusion criteria;
-Diagnosis of type 1 diabetes
-Patients with malignant tumor
-Patients with severe hepatic dysfunction
-Patients with severe renal dysfunction
-Patients with severe blood dyscraaia
-Patients with severe cardiovascular or pulmonary dysfunction
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method